Contracts & Grants

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member's name and school(s) appointments at The University of Texas Health Science Center at Houston, contracting or granting agency, funding amount and project title.

New

Corinne C. Aragaki, School of Public Health (SPH), The University of Texas Southwestern Medical Center, $11,139, Pathophysiological Biochemical Changes of Thermal Injury.

Shervin Assassi, Medical School (MS), American College of Rheumatology, $170,700, Peripheral Blood Cell Microarrays in Systemic Sclerosis.

R. Palmer Beasley, SPH, National Institutes of Health (NIH), John E. Fogarty International Center (FIC), $1,415,075, CITAR-The UT School of Public Health Program for Advanced Training on AIDS Research.

Rachel Brown, MS, American Heart Association, National, $260,000, TRPC Channels at the Blood-Brain Barrier: Role in Calcium Flux and Barrier Disruption after Hypoxic Stress.

Sheila Decker, School of Nursing, University of Iowa, $1,202, Pain Assessment in Minority Older Adults with Dementia: Evaluation of the PATCI.

Herbert L. Dupont, SPH and Graduate School of Biomedical Sciences (GSBS), Advanced Biologics, $2,223,001, A Multicenter, Double-Blind, Randomized Study to Compare the Safety and Efficacy of Prulifloxacin Versus Placebo in the Treatment of Adults with Acute Gastroenteritis in Travelers Protocol, Phase III; and Optimer Pharmaceuticals Inc., $296,400, A Multicenter, Double-Blind, Randomized Study to Compare the Safety and Efficacy of Prulifloxacin Versus Placebo in the Treatment of Acute Gastroenteritis in Adult Travelers, Phase III.

Linda Ewing-Cobbs, MS, University of Houston, $104,344, Cognitive, Instructional and Neuroimaging Factors in Math.

Adelaide A. Hebert, MS, Amgen Inc., $44,362, An Open-Label Extension Study to Evaluate the Safety of Etanercept in Pediatric Subjects with Plaque Psoriasis.

Jaou-Chen Huang, MS and GSBS, Southern Medical Association, $2,500, The Role of 1433E on Peroxisome Proliferator Activated Receptor Delta Medicated Embryo Survival.

Harinder S. Juneja, MS, Quintiles Inc., $48,864, A Phase III, Multicenter, 52-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Clinical Efficacy and Safety of ICA-17043 with or without Hydroxyurea Therapy in Patients with Sickle Cell Disease Who Have Had More than Two Acute Sickle-Related Painful Crises.

Lillian S. Kao, MS, NIH, National Center for Research Resources (NCRR), $674,840, Studies on Hyperglycemia in Surgical Infection.

Richard J. Kulmacz, MS and GSBS, Fred Hutchinson Cancer Research Center, $65,907, Prostaglandin Synthesis, Genetics and Colorectal Cancer.

Susan Landry, MS, Meadows Foundation, $120,000, Early Childhood Mathematics: Putting a Program in Place; Texas Education Agency, $1,301,789, Rural Texas Early Education Model (TEEM) Demonstration Program; and Texas Education Agency, $40,000, Stipends for Teachers of LEP Prekindergarten Teachers.

Jary M. Lesser, MS, Eisai Inc., $12,145, A 28-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Donepezil Hydrochloride in Subjects with Mild Cognitive Impairment; and Wyeth Pharmaceuticals, $80,721, A Multicenter, Randomized, Double-Blind, Long-Term Extension Study to Determine the Safety, Tolerability and Preliminary Long-Term Efficacy of Lecozotan SR in Patients with Mild to Moderate Alzheimer’s Disease.

Angela F. Meshack, SPH, Center for Border Health Research, $23,419, Smoke Free Youth Smoking Surveillance.

Frank I. Moore, SPH, UT San Antonio, $26,341, San Antonio Health Services Research Program Organizational Complexity and Decision Making in Health Facilities and Services in Relation to Quality Improvement, Patient Safety and Human Resource Management Practices.

Kristy O. Murray, SPH, Oregon Health Sciences University, $39,936, West Nile Virus Infection and Immunity in the Elderly: Mechanisms of Vulnerability.

Elizabeth Noser, MS, University of California - Irvine, $120,805, Randomized, Placebo-Controlled, Double-Blind Pilot Trial to Evaluate the Safety and Efficacy of Ropinirole in Motor Recovery after Stroke.

Andrew C. Papanicolaou, MS, University of Houston, $104,344, Cognitive, Instructional and Neuroimaging Factors in Math - Project 4.

Jimmy L. Perkins, SPH, City of San Antonio, $299,999, A Study to Evaluate the Health Effects of Air Pollution in Bexar County with a Focus on the Types of Emissions Associated with Coal-Fired Power Plants.

Susan M. Ramin, MS and GSBS, Cytokine Phamasciences Inc., $42,900, A Multicenter, Randomized, Double-Blind, Phase III Study of the Efficacy and Safety of the Misoprostol Vaginal Insert Compared to Cervidil for Women Requiring Cervical Ripening and Induction of Labor.

Blanca I. Restrepo, SPH, NIH, National Institute of Allergy and Infectious Diseases (NIAID), $408,375, Rapid Characterization of Mycobacteria and Drug Resistance in Paucibacillary TB.

Kevin D. Ridge, MS and GSBS, NIH, National Eye Institute, $1,035,021, Structural Analysis of the Rhodopsin-Transducin Complex.

Mya C. Schiess, MS, Allergan Inc., $20,000, Movement Disorders - Various Donors.

Jeremy Daniel Slater, MS, Epilepsy International Inc., $60,375, A Double-Blind, Randomized Study Comparing Levetiracetam and Carbamazepine in Elderly Patients with Partial Onset Seizures - Pilot Study; and Valeant Research and Development, $74,270, A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel- Group, Phase III Study to Determine the Efficacy and Safety of Retigabine (1200 Mg/Day) Used as Adjunctive Therapy in Refractory Epilepsy Patients with Partial-Onset Seizures.

Paul R. Swank, MS, Baylor College of Medicine, $92,472, Vascular Mechanisms of Secondary Injury after Traumatic Brain Injury.

Karen Uray, MS, NIH, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDKD), $428,672, Effects of Edema on Cadherins in Small Intestine.

Kim Waller, SPH, Texas Department of State Health Services, $67,495, Data Analysis for Existing Study, National Birth Defects Prevention Study.

Willy Wriggers, School of Health Information Sciences, GSBS and Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, Baylor College of Medicine, $3,000, Training Fellowship for Mirabela Rusu.

Anthony A. Wright, MS and GSBS, NIH, National Institute of Mental

Renewal

Jan M. Risser, SPH, City of Houston, $452,133, HIV Behavioral Surveillance in High Risk Heterosexual Population.

Agnes Schonbrunn, MS and GSBS, NIH, NIDDKD, $1,739,720, Function and Regulation of Somatostatin Receptors.

Supplemental

Roberto C. Arduino, MS, NIH, NIAID, $4,706,406, Houston AIDS Research Team (HART).

Sarah A. Felknor, SPH, NIH, FIC, $1,076,100, International Training and Research Program.

Maureen D. Mayes, MS, University of Tennessee, $147,082, Multicenter Phase II Trial of Oral Type I Bovine Collagen in Scleroderma.

Kevin A. Morano, MS, NIH, National Institute of General Medical Sciences, $1,306,078, HSP 110 Protein Chaperone Function in Yeast.

Susan Tortolero, SPH, Centers for Disease Control and Prevention, $13,733,556, Health Promotion and Disease Prevention Research Centers.

Transfer

James A. Katancik, NIH, NCRR, $8,534, Monocyte Tissue Factor Expression in Diabetes Mellitus.